Doxazosin treatment in cocaine use disorder: pharmacogenetic response based on an alpha-1 adrenoreceptor subtype D genetic variant

Pharmacogenetics of Dopamine β-Hydroxylase in cocaine dependence therapy with doxazosin

(2018) Xuefeng Zhang et al.   ADDICTION BIOLOGY

The α-1 adrenoceptor (ADRA1A) genotype moderates the magnitude of acute cocaine-induced subjective effects in cocaine-dependent individuals

(2016) Daryl Shorter et al.   Pharmacogenetics and Genomics

α2A-Adrenergic receptor polymorphisms and mRNA expression levels are associated with delay discounting in cocaine users

(2015) Michael M. Havranek et al.   ADDICTION BIOLOGY

Associations between catecholaminergic, GABAergic, and serotonergic genes and self-reported attentional function in oncology patients and their family caregivers

(2015) John D. Merriman et al.   European Journal of Oncology Nursing

Cardiovascular consequences of cocaine use

(2015) Rachel V. Stankowski et al.   TRENDS IN CARDIOVASCULAR MEDICINE

Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol

(2013) Wilson M. Compton et al.   DRUG AND ALCOHOL DEPENDENCE

The alpha-1 adrenergic antagonist doxazosin for treatment of cocaine dependence: A pilot study

(2013) D. Shorter et al.   DRUG AND ALCOHOL DEPENDENCE

Pharmacogenetic randomized trial for cocaine abuse: Disulfiram and α1A-adrenoceptor gene variation

(2013) D. Shorter et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Involvement of the α1D-adrenergic Receptor in Methamphetamine-Induced Hyperthermia and Neurotoxicity in Rats

(2013) Kazue Kikuchi-Utsumi et al.   NEUROTOXICITY RESEARCH

Pharmacogenetic Randomized Trial for Cocaine Abuse: Disulfiram and Dopamine β-Hydroxylase

(2012) Thomas R. Kosten et al.   BIOLOGICAL PSYCHIATRY

Modifying the role of serotonergic5-HTTLPRandTPH2variants on disulfiram treatment of cocaine addiction: a preliminary study

(2012) D. A. Nielsen et al.   GENES BRAIN AND BEHAVIOR

Clinical Response and Side Effects of Metoclopramide

(2012) Henry P. Parkman et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Noradrenergic α1 Receptor Antagonist Treatment Attenuates Positive Subjective Effects of Cocaine in Humans: A Randomized Trial

(2012) Thomas F. Newton et al.   PLoS One

Cardiovascular Pharmacogenomics of Adrenergic Receptor Signaling: Clinical Implications and Future Directions

(2011) J A Johnson et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Cardiac and neuroprotection regulated by α1-adrenergic receptor subtypes

(2011) Dianne M. Perez et al.   JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION

Cholinergic modulation of mesolimbic dopamine function and reward

(2011) Gregory P. Mark et al.   PHYSIOLOGY & BEHAVIOR

Addiction: Beyond dopamine reward circuitry

(2011) N. D. Volkow et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Domperidone Treatment for Gastroparesis: Demographic and Pharmacogenetic Characterization of Clinical Efficacy and Side-Effects

(2010) Henry P. Parkman et al.   DIGESTIVE DISEASES AND SCIENCES

Inferring weak population structure with the assistance of sample group information

(2009) MELISSA J. HUBISZ et al.   Molecular Ecology Resources

Amino Acids of the Human α1d-Adrenergic Receptor Involved in Antagonist Binding

(2008) Yuko Nagaoka et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

Role of α1-adrenoceptor subtypes in the effects of methylenedioxy methamphetamine (MDMA) on body temperature in the mouse

(2007) S Bexis et al.   BRITISH JOURNAL OF PHARMACOLOGY